{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["catechins", "chemotherapy", "drug resistance", "flavonoids", "functional food", "green tea", "microarray analysis", "natural products", "polyphenols"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32635587", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "19"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "07", "Day": "04"}], "Language": ["eng"], "ELocationID": ["1000", "10.3390/biom10071000"], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "10", "Issue": "7", "PubDate": {"Year": "2020", "Month": "Jul", "Day": "04"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Chemopreventive Property of Sencha Tea Extracts towards Sensitive and Multidrug-Resistant Leukemia and Multiple Myeloma Cells.", "Abstract": {"AbstractText": ["The popular beverage green tea possesses chemopreventive activity against various types of tumors. However, the effects of its chemopreventive effect on hematological malignancies have not been defined. In the present study, we evaluated antitumor efficacies of a specific green tea, sencha tea, on sensitive and multidrug-resistant leukemia and a panel of nine multiple myelomas (MM) cell lines. We found that sencha extracts induced cytotoxicity in leukemic cells and MM cells to different extents, yet its effect on normal cells was limited. Furthermore, sencha extracts caused G2/M and G0/G1 phase arrest during cell cycle progression in CCRF/CEM and KMS-12-BM cells, respectively. Specifically, sencha-MeOH/H<sub>2</sub>O extracts induced apoptosis, ROS, and MMP collapse on both CCRF/CEM and KMS-12-BM cells. The analysis with microarray and COMPARE in 53 cell lines of the NCI panel revealed diverse functional groups, including cell morphology, cellular growth and proliferation, cell cycle, cell death, and survival, which were closely associated with anti-tumor effects of sencha tea. It is important to note that PI3K/Akt and NF-\u03baB pathways were the top two dominant networks by ingenuity pathway analysis. We demonstrate here the multifactorial modes of action of sencha tea leading to chemopreventive effects of sencha tea against cancer."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Lu", "ForeName": "Xiaohua", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Saeed", "ForeName": "Mohamed E M", "Initials": "MEM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}, {"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, 12622 Giza, Egypt."}], "LastName": "Hegazy", "ForeName": "Mohamed-Elamir F", "Initials": "MF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department for Chemistry, Johannes Gutenberg University Mainz, Duesbergweg 10-14, 55128 Mainz, Germany."}], "LastName": "Kampf", "ForeName": "Christopher J", "Initials": "CJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Efferth", "ForeName": "Thomas", "Initials": "T"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Tea"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Drug Resistance, Multiple"}, {"QualifierName": ["drug effects"], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation, Neoplastic"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Leukemia"}, {"QualifierName": ["drug effects"], "DescriptorName": "Membrane Potential, Mitochondrial"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Multiple Myeloma"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["chemistry"], "DescriptorName": "Tea"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Cabrera C., Artacho R., Gim\u00e9nez R. Beneficial effects of green tea-a review. J. Am. Coll. Nutr. 2006;25:79\u201399. doi: 10.1080/07315724.2006.10719518.", "ArticleIdList": ["10.1080/07315724.2006.10719518", "16582024"]}, {"Citation": "Khan N., Mukhtar H. Tea polyphenols in promotion of human health. Nutrients. 2018;11:39. doi: 10.3390/nu11010039.", "ArticleIdList": ["10.3390/nu11010039", "PMC6356332", "30585192"]}, {"Citation": "Xing L., Zhang H., Qi R., Tsao R., Mine Y. Recent advances in the understanding of the health benefits and molecular mechanisms associated with green tea polyphenols. J. Agric. Food Chem. 2019;67:1029\u20131043. doi: 10.1021/acs.jafc.8b06146.", "ArticleIdList": ["10.1021/acs.jafc.8b06146", "30653316"]}, {"Citation": "Xu N., Chen Z.M. Green tea, black tea and semi-fermented tea. In: Zhen Y.S., Chen Z.M., Cheng S.J., Chen M.I., editors. Tea: Bioactivity and Therapeutic Potential. Taylor and Francis; London, UK: New York, NY, USA: 2002. pp. 35\u201355."}, {"Citation": "Tounekti T., Joubert E., Hern\u00e1ndez I., Munn\u00e9-Bosch S. Improving the polyphenol content of tea. Crit. Rev. Plant Sci. 2013;32:192\u2013215. doi: 10.1080/07352689.2012.747384.", "ArticleIdList": ["10.1080/07352689.2012.747384"]}, {"Citation": "\u0160ilarov\u00e1 P., \u010ceslov\u00e1 L., Meloun M. Fast gradient HPLC/MS separation of phenolics in green tea to monitor their degradation. Food Chem. 2017;237:471\u2013480. doi: 10.1016/j.foodchem.2017.05.133.", "ArticleIdList": ["10.1016/j.foodchem.2017.05.133", "28764022"]}, {"Citation": "He X., Li J., Zhao W., Liu R., Zhang L., Kong X. Chemical fingerprint analysis for quality control and identification of Ziyang green tea by HPLC. Food Chem. 2015;171:405\u2013411. doi: 10.1016/j.foodchem.2014.09.026.", "ArticleIdList": ["10.1016/j.foodchem.2014.09.026", "25308687"]}, {"Citation": "Ramdani D., Chaudhry A.S., Seal C.J. Alkaloid and polyphenol analysis by HPLC in green and black tea powders and their potential use as additives in ruminant diets. AIP Conf. Proc. 2018;1927:030008. doi: 10.1063/1.5021201.", "ArticleIdList": ["10.1063/1.5021201"]}, {"Citation": "Nakachi K., Matsuyama S., Miyake S., Suganuma M., Imai K. Preventive effects of drinking green tea on cancer and cardiovascular disease: Epidemiological evidence for multiple targeting prevention. BioFactors. 2000;13:49\u201354. doi: 10.1002/biof.5520130109.", "ArticleIdList": ["10.1002/biof.5520130109", "11237198"]}, {"Citation": "He Y.H., Kies C. Green and black tea consumption by humans: Impact on polyphenol concentrations in feces, blood and urine. Plant Foods Hum. Nutr. 1994;46:221\u2013229. doi: 10.1007/BF01088994.", "ArticleIdList": ["10.1007/BF01088994", "7855093"]}, {"Citation": "Chen L., Lee M.J., Li H., Yang C.S. Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metab. Dispos. 1997;25:1045\u20131050.", "ArticleIdList": ["9311619"]}, {"Citation": "Bianconi V., Mannarino M.R., Pirro M. Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project. Eur. J. Prev. Cardiol. 2020 doi: 10.1177/2047487319899206.", "ArticleIdList": ["10.1177/2047487319899206", "31914807"]}, {"Citation": "Khan N., Mukhtar H. Dietary agents for prevention and treatment of lung cancer. Cancer Lett. 2015;359:155\u2013164. doi: 10.1016/j.canlet.2015.01.038.", "ArticleIdList": ["10.1016/j.canlet.2015.01.038", "PMC4409137", "25644088"]}, {"Citation": "Wada K., Oba S., Tsuji M., Goto Y., Mizuta F., Koda S., Uji T., Hori A., Tanabashi S., Matsushita S., et al. Green tea intake and colorectal cancer risk in Japan: The Takayama study. Jpn. J. Clin. Oncol. 2019;49:515\u2013520. doi: 10.1093/jjco/hyz030.", "ArticleIdList": ["10.1093/jjco/hyz030", "30855678"]}, {"Citation": "Huang Y.Q., Lu X., Min H., Wu Q.Q., Shi X.T., Bian K.Q., Zou X.P. Green tea and liver cancer risk: A meta-analysis of prospective cohort studies in Asian populations. Nutrition. 2016;32:3\u20138. doi: 10.1016/j.nut.2015.05.021.", "ArticleIdList": ["10.1016/j.nut.2015.05.021", "26412579"]}, {"Citation": "Kumar N.B., Pow-Sang J., Egan K.M., Spiess P.E., Dickinson S., Salup R., Helal M., McLarty J., Williams C.R., Schreiber F., et al. Randomized, placebo-controlled trial of green tea catechins for prostate cancer prevention. Cancer Prev. Res. 2015;8:879\u2013887. doi: 10.1158/1940-6207.CAPR-14-0324.", "ArticleIdList": ["10.1158/1940-6207.CAPR-14-0324", "PMC4596745", "25873370"]}, {"Citation": "Yang G.Y., Liao J., Kim K., Yurkow E.J., Yang C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 1998;19:611\u2013616. doi: 10.1093/carcin/19.4.611.", "ArticleIdList": ["10.1093/carcin/19.4.611", "9600345"]}, {"Citation": "Seo E.J., Wu C.F., Ali Z., Wang Y.H., Khan S.I., Walker L.A., Khan I.A., Efferth T. Both phenolic and non-phenolic green tea fractions inhibit migration of cancer cells. Front. Pharmacol. 2016;7:1\u201316. doi: 10.3389/fphar.2016.00398.", "ArticleIdList": ["10.3389/fphar.2016.00398", "PMC5278262", "28194107"]}, {"Citation": "Srichairatanakool S., Ounjaijean S., Thephinlap C., Khansuwan U., Phisalpong C., Fucharoen S. Iron-chelating and free-radical scavenging activities of microwave-processed green tea in iron overload. Hemoglobin. 2006;30:311\u2013327. doi: 10.1080/03630260600642666.", "ArticleIdList": ["10.1080/03630260600642666", "16798656"]}, {"Citation": "Jankun J., Selman S.H., Swiercz R., Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature. 1997;387:561. doi: 10.1038/42381.", "ArticleIdList": ["10.1038/42381", "9177339"]}, {"Citation": "Ruch R.J., Cheng S.J., Klaunig J.E. Prevention of cytotoxicity and inhibition of intercellular communication by antioxidant catechins isolated from Chinese green tea. Carcinogenesis. 1989;10:1003\u20131008. doi: 10.1093/carcin/10.6.1003.", "ArticleIdList": ["10.1093/carcin/10.6.1003", "2470525"]}, {"Citation": "Rafat Husain S., Cillard J., Cillard P. Hydroxyl radical scavenging activity of flavonoids. Phytochemistry. 1987;26:2489\u20132491. doi: 10.1016/S0031-9422(00)83860-1.", "ArticleIdList": ["10.1016/S0031-9422(00)83860-1"]}, {"Citation": "Hou Z., Sang S., You H., Lee M.J., Hong J., Chin K.V., Yang C.S. Mechanism of Action of (\u2212)-Epigallocatechin-3-Gallate: Auto-oxidation\u2013dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 Cells. Cancer Res. 2005;65:8049\u20138056. doi: 10.1158/0008-5472.CAN-05-0480.", "ArticleIdList": ["10.1158/0008-5472.CAN-05-0480", "16140980"]}, {"Citation": "Chung L.Y., Cheung T.C., Kong S.K., Fung K.P., Choy Y.M., Chan Z.Y., Kwok T.T. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci. 2001;68:1207\u20131214. doi: 10.1016/S0024-3205(00)01020-1.", "ArticleIdList": ["10.1016/S0024-3205(00)01020-1", "11228105"]}, {"Citation": "Ly J.D., Grubb D.R., Lawen A. The mitochondrial membrane potential (\u0394\u03c8m) in apoptosis; an update. Apoptosis. 2003;8:115\u2013128. doi: 10.1023/A:1022945107762.", "ArticleIdList": ["10.1023/A:1022945107762", "12766472"]}, {"Citation": "Tajeddine N. How do reactive oxygen species and calcium trigger mitochondrial membrane permeabilisation? Biochim. Biophys. Acta. 2016;1860:1079\u20131088. doi: 10.1016/j.bbagen.2016.02.013.", "ArticleIdList": ["10.1016/j.bbagen.2016.02.013", "26922832"]}, {"Citation": "Thakur V.S., Gupta K., Gupta S. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis. 2011;33:377\u2013384. doi: 10.1093/carcin/bgr277.", "ArticleIdList": ["10.1093/carcin/bgr277", "PMC3499108", "22114073"]}, {"Citation": "Qin J., Xie L.P., Zheng X.Y., Wang Y.B., Bai Y., Shen H.-F., Li L.C., Dahiya R. A component of green tea, (\u2212)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem. Biophys. Res. Commun. 2007;354:852\u2013857. doi: 10.1016/j.bbrc.2007.01.003.", "ArticleIdList": ["10.1016/j.bbrc.2007.01.003", "17266926"]}, {"Citation": "Ahmad N., Gupta S., Mukhtar H. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor \u03baB in cancer cells versus normal cells. Arch. Biochem. Biophys. 2000;376:338\u2013346. doi: 10.1006/abbi.2000.1742.", "ArticleIdList": ["10.1006/abbi.2000.1742", "10775421"]}, {"Citation": "Gu J.W., Makey K.L., Tucker K.B., Chinchar E., Mao X., Pei I., Thomas E.Y., Miele L. EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1\u03b1 and NF\u03baB, and VEGF expression. Vasc. Cell. 2013;5:9. doi: 10.1186/2045-824X-5-9.", "ArticleIdList": ["10.1186/2045-824X-5-9", "PMC3649947", "23638734"]}, {"Citation": "Terwilliger T., Abdul-Hay M. Acute lymphoblastic leukemia: A comprehensive review and 2017 update. Blood Cancer J. 2017;7:e577. doi: 10.1038/bcj.2017.53.", "ArticleIdList": ["10.1038/bcj.2017.53", "PMC5520400", "28665419"]}, {"Citation": "Turesson I., Bjorkholm M., Blimark C.H., Kristinsson S., Velez R., Landgren O. Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer survival. Eur. J. Haematol. 2018;101:237\u2013244. doi: 10.1111/ejh.13083.", "ArticleIdList": ["10.1111/ejh.13083", "PMC6195866", "29676004"]}, {"Citation": "Alexander D.D., Mink P.J., Adami H.O., Cole P., Mandel J.S., Oken M.M., Trichopoulos D. Multiple myeloma: A review of the epidemiologic literature. Int. J. Cancer. 2007;120(Suppl. 12):40\u201361. doi: 10.1002/ijc.22718.", "ArticleIdList": ["10.1002/ijc.22718", "17405120"]}, {"Citation": "Andres M., Feller A., Arndt V. Trends of incidence, mortality, and survival of multiple myeloma in Switzerland between 1994 and 2013. Cancer Epidemiol. 2018;53:105\u2013110. doi: 10.1016/j.canep.2018.01.015.", "ArticleIdList": ["10.1016/j.canep.2018.01.015", "29414629"]}, {"Citation": "Katz A.J., Chia V.M., Schoonen W.M., Kelsh M.A. Acute lymphoblastic leukemia: An assessment of international incidence, survival, and disease burden. Cancer Causes Control. 2015;26:1627\u20131642. doi: 10.1007/s10552-015-0657-6.", "ArticleIdList": ["10.1007/s10552-015-0657-6", "26376890"]}, {"Citation": "Maiso P., Huynh D., Moschetta M., Sacco A., Aljawai Y., Mishima Y., Asara J.M., Roccaro A.M., Kimmelman A.C., Ghobrial I.M. Metabolic signature identifies novel targets for drug resistance in multiple myeloma. Cancer Res. 2015;75:2071\u20132082. doi: 10.1158/0008-5472.CAN-14-3400.", "ArticleIdList": ["10.1158/0008-5472.CAN-14-3400", "PMC4433568", "25769724"]}, {"Citation": "Mansoori B., Mohammadi A., Davudian S., Shirjang S., Baradaran B. The different mechanisms of cancer drug resistance: A brief review. Adv. Pharm Bull. 2017;7:339\u2013348. doi: 10.15171/apb.2017.041.", "ArticleIdList": ["10.15171/apb.2017.041", "PMC5651054", "29071215"]}, {"Citation": "Fletcher J.I., Williams R.T., Henderson M.J., Norris M.D., Haber M. ABC transporters as mediators of drug resistance and contributors to cancer cell biology. Drug Resis. Updat. 2016;26:1\u20139. doi: 10.1016/j.drup.2016.03.001.", "ArticleIdList": ["10.1016/j.drup.2016.03.001", "27180306"]}, {"Citation": "Niruri R., Narayani I., Ariawati K., Herawati S. P-glycoprotein expression on patients with acute lymphoblastic leukemia. J. Health Sci. Med. 2017;1:39\u201341. doi: 10.24843/JHSM.2017.v01.i01.p10.", "ArticleIdList": ["10.24843/JHSM.2017.v01.i01.p10"]}, {"Citation": "Miyakoshi S., Kami M., Yuji K., Matsumura T., Takatoku M., Sasaki M., Narimatsu H., Fujii T., Kawabata M., Taniguchi S., et al. Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma. Blood. 2006;107:3492\u20133494. doi: 10.1182/blood-2005-11-4541.", "ArticleIdList": ["10.1182/blood-2005-11-4541", "16410442"]}, {"Citation": "Bockorny M., Bockorny M., Chakravarty S., Schulman P., Bockorny B., Bona R. Severe heart failure after bortezomib treatment in a patient with multiple myeloma: A case report and review of the literature. Acta Haematol. 2012;128:244\u2013247. doi: 10.1159/000340050.", "ArticleIdList": ["10.1159/000340050", "22964848"]}, {"Citation": "Stammler G., Volm M. Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines. Anticancer Drugs. 1997;8:265\u2013268. doi: 10.1097/00001813-199703000-00007.", "ArticleIdList": ["10.1097/00001813-199703000-00007", "9095331"]}, {"Citation": "Saeed M., Kuete V., Kadioglu O., B\u00f6rtzler J., Khalid H., Greten H.J., Efferth T. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Phytomedicine. 2014;21:1525\u20131533. doi: 10.1016/j.phymed.2014.07.011.", "ArticleIdList": ["10.1016/j.phymed.2014.07.011", "25442261"]}, {"Citation": "Kimmig A., Gekeler V., Neumann M., Frese G., Handgretinger R., Kardos G., Diddens H., Niethammer D. Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. Cancer Res. 1990;50:6793\u20136799.", "ArticleIdList": ["1698543"]}, {"Citation": "O\u2019Brien J., Wilson I., Orton T., Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000;267:5421\u20135426. doi: 10.1046/j.1432-1327.2000.01606.x.", "ArticleIdList": ["10.1046/j.1432-1327.2000.01606.x", "10951200"]}, {"Citation": "Efferth T., Sauerbrey A., Olbrich A., Gebhart E., Rauch P., Weber H.O., Hengstler J.G., Halatsch M.-E., Volm M., Tew K.D., et al. Molecular modes of action of artesunate in tumor cell lines. Mol. Pharmacol. 2003;64:382\u2013394. doi: 10.1124/mol.64.2.382.", "ArticleIdList": ["10.1124/mol.64.2.382", "12869643"]}, {"Citation": "Mbaveng A.T., Damen F., \u00c7elik \u0130., Tane P., Kuete V., Efferth T. Cytotoxicity of the crude extract and constituents of the bark of Fagara tessmannii towards multi-factorial drug resistant cancer cells. J. Ethnopharmacol. 2019;235:28\u201337. doi: 10.1016/j.jep.2019.01.031.", "ArticleIdList": ["10.1016/j.jep.2019.01.031", "30703492"]}, {"Citation": "Mbaveng A.T., Damen F., Simo Mpetga J.D., Awouafack M.D., Tane P., Kuete V., Efferth T. Cytotoxicity of crude extract and isolated constituents of the dichrostachys cinerea bark towards multifactorial drug-resistant cancer cells. Evid. Based Complement. Alternat. Med. 2019;2019:1\u201311. doi: 10.1155/2019/8450158.", "ArticleIdList": ["10.1155/2019/8450158", "PMC6644236", "31360210"]}, {"Citation": "Abdelfatah S., Fleischer E., Klinger A., Wong V.K.W., Efferth T. Identification of inhibitors of the polo-box domain of polo-like kinase 1 from natural and semisynthetic compounds. Invest. New Drugs. 2019;2019:1\u20139. doi: 10.1007/s10637-019-00752-0.", "ArticleIdList": ["10.1007/s10637-019-00752-0", "30877426"]}, {"Citation": "Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 1975;66:188\u2013193. doi: 10.1083/jcb.66.1.188.", "ArticleIdList": ["10.1083/jcb.66.1.188", "PMC2109516", "49354"]}, {"Citation": "Vermes I., Haanen C., Steffens-Nakken H., Reutellingsperger C. A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods. 1995;184:39\u201351. doi: 10.1016/0022-1759(95)00072-I.", "ArticleIdList": ["10.1016/0022-1759(95)00072-I", "7622868"]}, {"Citation": "Rescher U., Gerke V. Annexins\u2014Unique membrane binding proteins with diverse functions. J. Cell Sci. 2004;117:2631\u20132639. doi: 10.1242/jcs.01245.", "ArticleIdList": ["10.1242/jcs.01245", "15169834"]}, {"Citation": "Cossarizza A., Ferraresi R., Troiano L., Roat E., Gibellini L., Bertoncelli L., Nasi M., Pinti M. Simultaneous analysis of reactive oxygen species and reduced glutathione content in living cells by polychromatic flow cytometry. Nat. Protoc. 2009;4:1790\u20131797. doi: 10.1038/nprot.2009.189.", "ArticleIdList": ["10.1038/nprot.2009.189", "20010930"]}, {"Citation": "\u00d6zenver N., Saeed M., Demirezer L.\u00d6., Efferth T. Aloe-emodin as drug candidate for cancer therapy. Oncotarget. 2018;9:17770\u201317796. doi: 10.18632/oncotarget.24880.", "ArticleIdList": ["10.18632/oncotarget.24880", "PMC5915154", "29707146"]}, {"Citation": "Amundson S.A., Do K.T., Vinikoor L.C., Lee R.A., Koch-Paiz C.A., Ahn J., Reimers M., Chen Y., Scudiero D.A., Weinstein J.N., et al. Integrating global gene expression and radiation survival parameters across the 60 cell Lines of the national cancer institute anticancer drug screen. Cancer Res. 2008;68:415\u2013424. doi: 10.1158/0008-5472.CAN-07-2120.", "ArticleIdList": ["10.1158/0008-5472.CAN-07-2120", "18199535"]}, {"Citation": "Paull K.D., Shoemaker R.H., Hodes L., Monks A., Scudiero D.A., Rubinstein L., Plowman J., Boyd M.R. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm. J. Natl. Cancer Inst. 1989;81:1088\u20131092. doi: 10.1093/jnci/81.14.1088.", "ArticleIdList": ["10.1093/jnci/81.14.1088", "2738938"]}, {"Citation": "Fagan V., Bonham S., Carty M.P., Saenz-Mendez P., Eriksson L.A., Aldabbagh F. COMPARE analysis of the toxicity of an iminoquinone derivative of the imidazo[5,4-f]benzimidazoles with NAD(P)H:quinone oxidoreductase 1 (NQO1) activity and computational docking of quinones as NQO1 substrates. Bioorg. Med. Chem. 2012;20:3323\u20133332. doi: 10.1016/j.bmc.2012.03.063.", "ArticleIdList": ["10.1016/j.bmc.2012.03.063", "22522008"]}, {"Citation": "Saeed M.E.M., Mahmoud N., Sugimoto Y., Efferth T., Abdel-Aziz H. Molecular determinants of sensitivity or resistance of cancer cells toward sanguinarine. Front. Pharmacol. 2018;9:1\u201315. doi: 10.3389/fphar.2018.00136.", "ArticleIdList": ["10.3389/fphar.2018.00136", "PMC5834429", "29535628"]}, {"Citation": "Dawood M., Hamdoun S., Efferth T. Multifactorial modes of action of arsenic trioxide in cancer cells as analyzed by classical and network pharmacology. Front. Pharmacol. 2018;9:1\u201319. doi: 10.3389/fphar.2018.00143.", "ArticleIdList": ["10.3389/fphar.2018.00143", "PMC5835320", "29535630"]}, {"Citation": "Kadioglu O., Efferth T. Pharmacogenomic characterization of cytotoxic compounds from salvia officinalis in cancer cells. J. Nat. Prod. 2015;78:762\u2013775. doi: 10.1021/np501007n.", "ArticleIdList": ["10.1021/np501007n", "25713926"]}, {"Citation": "Jim\u00e9nez-Mar\u00edn \u00c1., Collado-Romero M., Ramirez-Boo M., Arce C., Garrido J.J. Biological pathway analysis by ArrayUnlock and Ingenuity Pathway Analysis. BMC Proc. 2009;3:S6. doi: 10.1186/1753-6561-3-s4-s6.", "ArticleIdList": ["10.1186/1753-6561-3-s4-s6", "PMC2712749", "19615119"]}, {"Citation": "Jia P., Kao C.F., Kuo P.H., Zhao Z. A comprehensive network and pathway analysis of candidate genes in major depressive disorder. BMC Syst. Biol. 2011;5:S12. doi: 10.1186/1752-0509-5-S3-S12.", "ArticleIdList": ["10.1186/1752-0509-5-S3-S12", "PMC3287567", "22784618"]}, {"Citation": "Natrajan R., Weigelt B., Mackay A., Geyer F.C., Grigoriadis A., Tan D.S.P., Jones C., Lord C.J., Vatcheva R., Rodriguez-Pinilla S.M., et al. An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast Cancer Res. Treat. 2010;121:575\u2013589. doi: 10.1007/s10549-009-0501-3.", "ArticleIdList": ["10.1007/s10549-009-0501-3", "19688261"]}, {"Citation": "Dawood M., Ooko E., Efferth T. Collateral sensitivity of parthenolide via NF-kappaB and HIF-alpha inhibition and epigenetic changes in drug-resistant cancer cell lines. Front. Pharmacol. 2019;10:1\u201316. doi: 10.3389/fphar.2019.00542.", "ArticleIdList": ["10.3389/fphar.2019.00542", "PMC6536578", "31164821"]}, {"Citation": "Allard P.M., P\u00e9resse T., Bisson J., Gindro K., Marcourt L., Pham V.C., Roussi F., Litaudon M., Wolfender J.L. Integration of molecular networking and in-silico MS/MS fragmentation for natural products dereplication. Anal. Chem. 2016;88:3317\u20133323. doi: 10.1021/acs.analchem.5b04804.", "ArticleIdList": ["10.1021/acs.analchem.5b04804", "26882108"]}, {"Citation": "Otto T., Sicinski P. Cell cycle proteins as promising targets in cancer therapy. Nat. Rev. Cancer. 2017;17:93\u2013115. doi: 10.1038/nrc.2016.138.", "ArticleIdList": ["10.1038/nrc.2016.138", "PMC5345933", "28127048"]}, {"Citation": "Peng G., Wargovich M.J., Dixon D.A. Anti-proliferative effects of green tea polyphenol EGCG on Ha-Ras-induced transformation of intestinal epithelial cells. Cancer Lett. 2006;238:260\u2013270. doi: 10.1016/j.canlet.2005.07.018.", "ArticleIdList": ["10.1016/j.canlet.2005.07.018", "16157446"]}, {"Citation": "Ahmad N., Feyes D.K., Agarwal R., Mukhtar H., Nieminen A.L. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. 1997;89:1881\u20131886. doi: 10.1093/jnci/89.24.1881.", "ArticleIdList": ["10.1093/jnci/89.24.1881", "9414176"]}, {"Citation": "Forester S.C., Lambert J.D. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol. Nutr. Food Res. 2011;55:844\u2013854. doi: 10.1002/mnfr.201000641.", "ArticleIdList": ["10.1002/mnfr.201000641", "PMC3679539", "21538850"]}, {"Citation": "Ott M., Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis. 2007;12:913\u2013922. doi: 10.1007/s10495-007-0756-2.", "ArticleIdList": ["10.1007/s10495-007-0756-2", "17453160"]}, {"Citation": "Indo H.P., Davidson M., Yen H.C., Suenaga S., Tomita K., Nishii T., Higuchi M., Koga Y., Ozawa T., Majima H.J. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion. 2007;7:106\u2013118. doi: 10.1016/j.mito.2006.11.026.", "ArticleIdList": ["10.1016/j.mito.2006.11.026", "17307400"]}, {"Citation": "Trachootham D., Alexandre J., Huang P. Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nat. Rev. Drug Discov. 2009;8:579\u2013591. doi: 10.1038/nrd2803.", "ArticleIdList": ["10.1038/nrd2803", "19478820"]}, {"Citation": "Ran Z.H., Xu Q., Tong J.L., Xiao S.D. Apoptotic effect of Epigallocatechin-3-gallate on the human gastric cancer cell line MKN45 via activation of the mitochondrial pathway. World J. Gastroenterol. 2007;13:4255\u20134259. doi: 10.3748/wjg.v13.i31.4255.", "ArticleIdList": ["10.3748/wjg.v13.i31.4255", "PMC4250627", "17696257"]}, {"Citation": "Efferth T., Koch E. Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr. Drug Targets. 2011;12:122\u2013132. doi: 10.2174/138945011793591626.", "ArticleIdList": ["10.2174/138945011793591626", "20735354"]}, {"Citation": "Mancini M., Yarden Y. Mutational and network level mechanisms underlying resistance to anti-cancer kinase inhibitors. Semin. Cell Dev. Biol. 2016;50:164\u2013176. doi: 10.1016/j.semcdb.2015.09.018.", "ArticleIdList": ["10.1016/j.semcdb.2015.09.018", "26428295"]}, {"Citation": "Efferth T., Konkimalla V.B., Wang Y.F., Sauerbrey A., Meinhardt S., Zintl F., Mattern J., Volm M. Prediction of broad spectrum resistance of tumors towards anticancer drugs. Clin. Cancer Res. 2008;14:2405\u20132412. doi: 10.1158/1078-0432.CCR-07-4525.", "ArticleIdList": ["10.1158/1078-0432.CCR-07-4525", "18413831"]}, {"Citation": "Davis T.B., Yang M., Wang H., Lee C., Yeatman T.J., Pledger W.J. PTPRS drives adaptive resistance to MEK/ERK inhibitors through SRC. Oncotarget. 2019;10:6768\u20136780. doi: 10.18632/oncotarget.27335.", "ArticleIdList": ["10.18632/oncotarget.27335", "PMC6887575", "31827720"]}, {"Citation": "Byrgazov K., Kastner R., Gorna M., Hoermann G., Koenig M., Lucini C.B., Ulreich R., Benesch M., Strenger V., Lackner H., et al. NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitors. Leukemia. 2017;31:237\u2013240. doi: 10.1038/leu.2016.250.", "ArticleIdList": ["10.1038/leu.2016.250", "PMC5220134", "27573554"]}, {"Citation": "Zeng A.L., Yan W., Liu Y.W., Wang Z., Hu Q., Nie E., Zhou X., Li R., Wang X.F., Jiang T., et al. Tumour exosomes from cells harbouring PTPRZ1\u2013MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma. Oncogene. 2017;36:5369\u20135381. doi: 10.1038/onc.2017.134.", "ArticleIdList": ["10.1038/onc.2017.134", "PMC5611480", "28504721"]}, {"Citation": "Jiang L., Chan J.Y.W., Fung K.P. Epigenetic loss of CDH1 correlates with multidrug resistance in human hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 2012;422:739\u2013744. doi: 10.1016/j.bbrc.2012.05.072.", "ArticleIdList": ["10.1016/j.bbrc.2012.05.072", "22634315"]}, {"Citation": "Fu X., Feng J., Zeng D., Ding Y., Yu C., Yang B. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways. Biosci. Rep. 2014;34 doi: 10.1042/BSR20130102.", "ArticleIdList": ["10.1042/BSR20130102", "PMC3941610", "27919028"]}, {"Citation": "Yang F., Fang H., Wang D., Chen Y., Zhai Y., Zhou B.-B.S., Li H. HPRT1 activity loss is associated with resistance to thiopurine in ALL. Oncotarget. 2017;9:2268\u20132278. doi: 10.18632/oncotarget.23405.", "ArticleIdList": ["10.18632/oncotarget.23405", "PMC5788638", "29416770"]}, {"Citation": "Tsofack S.P., Meunier L., Sanchez L., Madore J., Provencher D., Mes-Masson A.M., Lebel M. Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis. BMC Cancer. 2013;13:303. doi: 10.1186/1471-2407-13-303.", "ArticleIdList": ["10.1186/1471-2407-13-303", "PMC3708827", "23800275"]}, {"Citation": "Chang F., Lee J.T., Navolanic P.M., Steelman L.S., Shelton J.G., Blalock W.L., Franklin R.A., McCubrey J.A. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: A target for cancer chemotherapy. Leukemia. 2003;17:590\u2013603. doi: 10.1038/sj.leu.2402824.", "ArticleIdList": ["10.1038/sj.leu.2402824", "12646949"]}, {"Citation": "Shankar S., Chen Q., Srivastava R.K. Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor. J. Mol. Signal. 2008;3:7. doi: 10.1186/1750-2187-3-7.", "ArticleIdList": ["10.1186/1750-2187-3-7", "PMC2278143", "18355401"]}, {"Citation": "Hoesel B., Schmid J.A. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol. Cancer. 2013;12:86. doi: 10.1186/1476-4598-12-86.", "ArticleIdList": ["10.1186/1476-4598-12-86", "PMC3750319", "23915189"]}, {"Citation": "Xia Y., Shen S., Verma I.M. NF-\u03baB, an active player in human cancers. Cancer Immunol. Res. 2014;2:823\u2013830. doi: 10.1158/2326-6066.CIR-14-0112.", "ArticleIdList": ["10.1158/2326-6066.CIR-14-0112", "PMC4155602", "25187272"]}, {"Citation": "Kordes U., Krappmann D., Heissmeyer V., Ludwig W.D., Scheidereit C. Transcription factor NF-\u03baB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia. 2000;14:399\u2013402. doi: 10.1038/sj.leu.2401705.", "ArticleIdList": ["10.1038/sj.leu.2401705", "10720133"]}, {"Citation": "Tang X., Liu D., Shishodia S., Ozburn N., Behrens C., Lee J.J., Hong W.K., Aggarwal B.B., Wistuba I.I. Nuclear factor-\u03baB (NF-\u03baB) is frequently expressed in lung cancer and preneoplastic lesions. Cancer. 2006;107:2637\u20132646. doi: 10.1002/cncr.22315.", "ArticleIdList": ["10.1002/cncr.22315", "17078054"]}, {"Citation": "Suhail M., Perveen A., Husain A., Rehan M. Exploring inhibitory mechanisms of green tea catechins as inhibitors of a cancer therapeutic target, nuclear factor-\u03baB (NF-\u03baB) Biosci. Biotech. Res Asia. 2019;16 doi: 10.13005/bbra/2787.", "ArticleIdList": ["10.13005/bbra/2787"]}, {"Citation": "Luo K.W., Wei C., Lung W.Y., Wei X.Y., Cheng B.H., Cai Z.M., Huang W.R. EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-\u03baB and MMP-9. J. Nutr. Biochem. 2017;41:56\u201364. doi: 10.1016/j.jnutbio.2016.12.004.", "ArticleIdList": ["10.1016/j.jnutbio.2016.12.004", "28040581"]}, {"Citation": "Lagha A.B., Grenier D. Tea polyphenols inhibit the activation of NF-\u03baB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum. Sci. Rep. 2016;6:34520. doi: 10.1038/srep34520.", "ArticleIdList": ["10.1038/srep34520", "PMC5046134", "27694921"]}]}], "History": [{"Year": "2020", "Month": "5", "Day": "22"}, {"Year": "2020", "Month": "7", "Day": "1"}, {"Year": "2020", "Month": "7", "Day": "2"}, {"Year": "2020", "Month": "7", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "7", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32635587", "PMC7407630", "10.3390/biom10071000", "biom10071000"]}}]}